Whoop’s FDA Run-In Shows the Real Line for Wearable Health Claims
Whoop’s recent clash with regulators over its blood pressure estimation feature, and the emergence of third-party apps that bypass its subscription model, together illustrate how consumer wearables are testing the blurry boundary between wellness tools and regulated medical devices.
Last August, the FDA contacted Whoop about concerns with its blood pressure analysis and whether those features pushed the product into medical-device territory. Instead of yanking the tool, the company pushed back and kept blood pressure support live while it negotiated a fix. This week, regulators signed off on a compromise: Whoop can continue the feature if it strips out labels that mark blood pressure as “normal” or “elevated” and reframes everything as wellness insight rather than diagnosis. In parallel, independent developers have been quietly working out how to talk to old Whoop straps over Bluetooth, letting users pull heart rate and motion data without the official app or any membership at all. Together, these moves show that, for now, the real risk line is about claims and control, not sensors and silicon.
From Warning Letter to Green Light: How Whoop Defused FDA Enforcement
The FDA did something important here: it backed away from enforcement once Whoop toned down its language instead of its feature set. Nearly a year after warning the company about its blood pressure tracker, the agency confirmed it will not take enforcement action against Whoop’s tool. According to a report citing the negotiations, the FDA has now formally given Whoop permission to keep offering blood pressure analysis, provided the company changes how the feature is described.
Like many other wearables, Whoop’s band cannot measure blood pressure directly; it relies on users taking an initial reading with an inflatable cuff and then extrapolates changes from the sensors it does have. The technical approach didn’t change; the labels did. The app will no longer flag blood pressure as normal or elevated and instead frames its output as wellness-oriented context rather than medical judgment. That may sound like hair-splitting, but it matters: "the FDA formally gave WHOOP the go-ahead for continuing to offer its blood pressure tool earlier this week." Users get to keep the feature, and regulators get a precedent that signals language is as consequential as code.
Subscription Wearables Meet Indie Hackers: Noop, Goose, and the New Data Underground
While regulators wrangled over labels, a different kind of pressure built from below. Whoop’s business rests on a tight integration of hardware, software, and a subscription: the strap streams heart rate and motion data to the app, which ships it to the cloud, and in return members paying around USD 239 (approx. RM1115) per year get recovery, strain, and sleep analytics. Its higher-end WHOOP MG is tied to a “Life” plan starting at USD 359 (approx. RM1675) annually. The hardware itself, meanwhile, steadily marches from 4.0 to 5.0, with many users upgrading and leaving older straps behind as e‑waste.
Independent developers saw an opportunity. Projects like Noop, Goose, Wearable, and others set out to speak the Whoop band’s Bluetooth Low Energy dialect directly, without going through the official app. One earlier tool, Whoomp, let a browser page show live heart rate and even buzz the strap using a dormant 4.0 device. The new generation goes further: they aim to let individuals use Whoop hardware without any contact with the company and without ever having had a subscription. If a free app can read the device’s data over Bluetooth, you can use the strap for your own purposes without the Whoop app or service. That is not a minor tweak; it is a challenge to the idea that access to your own body data should be paywalled.
Takedown Requests, Open Protocols, and Who Owns Your Wrist Data
Whoop has not ignored this indie ecosystem. The company says it welcomes third-party development through its official API, so long as developers pull data that Whoop has already processed and users remain paying members inside its system. These new projects refuse that premise by pairing directly with the strap. As one developer explained, a fresh Whoop device broadcasts enough over Bluetooth for a phone or computer to bond with it if the right “language” is decoded. That decoding took years of slow trial and error because Whoop never published its Bluetooth protocol.
When those breakthroughs finally surfaced on Reddit and GitHub, more apps appeared in rapid succession. Some did not last. Whoomp vanished from GitHub after a request from Whoop’s VP of software, who also contacted another developer behind the Wearable project with a similar takedown ask. Not everyone complied; some code remains online. The legal lines here are contested, but the user stakes are clear: independent apps promise greater privacy, reuse of old hardware, and freedom from perpetual fees. In the words of one observer, an independent app is a way “to keep your data private and to make use of an otherwise obsolete piece of hardware.”
A Gray Zone with High Stakes: Where Wearables Go from Here
Taken together, Whoop’s regulatory outcome and its underground app scene sketch a future where hardware, services, and rules are far less tightly coupled than companies would prefer. On the regulatory side, wearable blood pressure regulation is implicitly tilting toward controlling how features are framed rather than banning complex sensor interpretations outright; the risk is that language becomes a fig leaf for medical behavior when what users want is clarity.
On the business and user side, the separation of hardware from software and services is no longer hypothetical. These independent projects explicitly aim to let people use Whoop devices without any contact with the company or its cloud. Because a free app can read data over Bluetooth, users can reclaim straps that would otherwise be junk and keep intimate physiological data off corporate servers. The trade-offs are real—no proprietary coaching, no official support—but so is the shift in power. This is the new bargain for wearables: if companies want subscription revenue and regulatory goodwill, they will have to accept that the sensor on your wrist does not belong to them, and neither does the story it tells about your body.
